Editorial for Treatment-Resistant Depression (TRD)

Affiliations

¹ Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria.
² Department of Pharmacology, UT Health San Antonio, Texas.

Editorial

Siegfried Kasper et al. Int J Neuropsychopharmacol. 2019.

. 2019 Feb 1;22(2):83-84.

doi: 10.1093/ijnp/pyz006.

¹ Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria.
² Department of Pharmacology, UT Health San Antonio, Texas.

No abstract available

References

1. Bartova L, Dold M, Kautzky A, Serretti A, Souery D, Mendlewicz J, Zohar J, Montgomery S, Schosser A, Kasper S (2019) Results of the European Group for the study of resistant depression (GSRD)—basis for further research and clinical practice. World J Biol Psychiatry (submitted) - PubMed
1. Cipriani A, Furukawa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y, Leucht S, Ruhe HG, Turner EH, Higgins JPT, Egger M, Takeshima N, Hayasaka Y, Imai H, Shinohara K, Tajika A, Ioannidis JPA, Geddes JR (2018) Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet 391:1357–1366. - PMC - PubMed
1. Clinical Pharmacogenetics Implementation Consortium (2014) CPIC Guidelines. Available at: https://cpicpgx.org/guidelines/ Accessed November 27, 2017.
1. Demyttenaere K, Van Duppen Z (2018) The impact of (the Concept of) treatment-resistant depression: an opinion review. Int J Neuropsychopharmacol doi: 10.1093/ijnp/pyy052. - DOI - PMC - PubMed
1. Dold M, Kasper S (2017) Evidence-based pharmacotherapy of treatment-resistant unipolar depression. Int J Psychiatry Clin Pract 21:13–23. - PubMed